SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-010823
Filing Date
2012-11-01
Accepted
2012-11-01 16:41:38
Documents
3
Period of Report
2012-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K furx20121031_8k.htm 8-K 18651
2 EXHIBIT 99.1 furx20121031_8kex99-1.htm EX-99 139978
3 furx20121031_8kimg1.jpg GRAPHIC 6889
  Complete submission text file 0001437749-12-010823.txt   169514
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34641 | Film No.: 121174064
SIC: 2834 Pharmaceutical Preparations